Options
番茄素定抑制人類骨肉瘤細胞株其侵襲與轉移之機制探討
Date Issued
2020
Author(s)
謝明宏
Min-Hong Hsieh
Advisor
張浤榮
Abstract
研究目的:骨肉瘤好發於小兒,是最普遍之惡性骨腫瘤,大部分骨肉瘤其預後不良多是因其具有高度轉移能力所導致。而番茄素定(tomatidine)可能具有抗轉移能力的特性。但截至目前為止番茄素定對人類骨肉瘤轉移的作用尚不清楚;因此,我們探討番茄素定是否能影響人類骨肉瘤細胞遷移與侵襲並釐清其相關的機轉。研究方法:我們選取兩種骨肉瘤細胞株U2OS及HOS,培養後進行番茄素定對腫瘤細胞存活率的分析、細胞遷移性試驗與細胞侵入性試驗,對已處理番茄素定24小時的腫瘤細胞進行蛋白質萃取及定量,以西方墨點法進行各種欲觀察之傳遞路徑蛋白定量,以及其對應之RNA萃取及定量,並將PS-1與ERK knock down之後,觀察兩者對於腫瘤細胞的侵襲與遷移的影響。研究結果:當番茄素定的濃度達100 µM時,對癌細胞並無毒性,並可抑制人類骨肉瘤U2OS和HOS細胞株的侵襲和遷移能力,使U2OS細胞其早老素1 (presenilin 1, PS-1)表現降低。抑制PS-1表現後U2OS和HOS細胞其侵襲和遷移的能力顯著減少。我們觀察到在U2OS細胞上,番茄素定可顯著降低其c-Raf、mitogen/extracellular signal-regulated kinase (MEK) 和extracellular signal-regulated protein kinase(ERK1/2)的磷酸化,對於Jun N-terminal kinase (JNK)、p38和Akt及其磷酸化則沒有明顯影響。在U2OS細胞中減少ERK 1基因表現時,番茄素定可進一步降低腫瘤細胞的遷移和侵襲能力。 結論與建議:我們的結論是,源自於U2OS和HOS細胞的PS-1和c-Raf–MEK–ERK訊息傳遞路徑兩者均有助於細胞侵襲和遷移,而番茄素定可以抑制這種現象。這些研究指出番茄素定可以作為對抗人類骨肉瘤轉移治療的輔助藥物。
Osteosarcoma, the most prevalent malignant bone tumor, is responsible for the great majority of bone cancer-associated deaths because of its highly metastatic potential. Although tomatidine is suggested to serve as a chemosensitizer in multidrug-resistant tumors, the anti-metastatic effect of tomatidine in osteosarcoma is still unknown. Here, we tested the hypothesis that tomatidine suppresses migration and invasion, features that are associated with metastatic process in human osteosarcoma cells and also investigate its underlying pathway. Tomatidine, up to 100 µM, without cytotoxicity, inhibited the invasion and migration capabilities of human osteosarcoma U2OS and HOS cells and repressed presenilin 1 (PS-1) expression of U2OS cells. After the knockdown of PS-1, U2OS and HOS cells’ biological behaviors of cellular invasion and migratory potential were significantly reduced. While tomatidine significantly decreased the phosphorylation of c-Raf, mitogen/extracellular signal-regulated kinase (MEK), and extracellular signal-regulated protein kinase (ERK)1/2 in U2OS cells, no obvious influences on p-Jun N-terminal kinase, p38, and Akt, including their phosphorylation, were observed. In ERK 1 silencing U2 OS cells, tomatidine further enhanced the decrease of their migratory potential and invasive activities. We conclude that both PS-1 derived from U2OS and HOS cells and the c-Raf–MEK–ERK pathway contribute to cellular invasion and migration and tomatidine could inhibit the phenomenons. These findings indicate that tomatidine might be a potential candidate for anti-metastasis treatment of human osteosarcoma.
Subjects
細胞外訊息調節蛋白激酶
轉移
骨肉瘤
早老素1
番茄素定
ERK
metastasis
osteosarcoma
PS-1
tomatidine
Type
thesis
File(s)
No Thumbnail Available
Name
108CSMU5534014-001.zip
Size
1.51 MB
Format
Unknown
Checksum
(MD5):f91a03835e30d09548c3142246d576f3